SE382560B - Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring - Google Patents

Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring

Info

Publication number
SE382560B
SE382560B SE7112796A SE1279671A SE382560B SE 382560 B SE382560 B SE 382560B SE 7112796 A SE7112796 A SE 7112796A SE 1279671 A SE1279671 A SE 1279671A SE 382560 B SE382560 B SE 382560B
Authority
SE
Sweden
Prior art keywords
complex
procedure
preparation
acceptable salts
salicylic acid
Prior art date
Application number
SE7112796A
Other languages
English (en)
Swedish (sv)
Inventor
S Casadio
E Sclavi
R Perego
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of SE382560B publication Critical patent/SE382560B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7112796A 1970-10-09 1971-10-08 Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring SE382560B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4816770A GB1357737A (en) 1970-10-09 1970-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE382560B true SE382560B (sv) 1976-02-09

Family

ID=10447626

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7112796A SE382560B (sv) 1970-10-09 1971-10-08 Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring

Country Status (8)

Country Link
US (1) US3853988A (OSRAM)
CA (1) CA974883A (OSRAM)
DE (1) DE2149699A1 (OSRAM)
DK (1) DK129434B (OSRAM)
ES (1) ES395533A1 (OSRAM)
FR (1) FR2110314B1 (OSRAM)
GB (1) GB1357737A (OSRAM)
SE (1) SE382560B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
FR2653338B1 (fr) * 1989-10-23 1994-06-10 Dow Corning Sa Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
DE4409357C2 (de) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Verwendung von Dimeticon zur Eradikation von Heliobacter pylori
CZ300696A3 (en) * 1994-03-18 1997-09-17 Alfred Schmidt USE OF DEMETICON FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR LOCAL AND ANTIBACTERIAL THERAPY AND/OR PREVENTION AND THERAPY OF SYNDROMES AND INFECTIOUS DISEASES CONNECTED WITH HELIOBACTER PYLORI (Hp)
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1997002019A1 (en) * 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials
US20110039807A1 (en) * 2009-08-13 2011-02-17 Kim Hyoung-Chun Anti-parkinsonian compound acetylsalicylic acid maltol ester
WO2014014753A1 (en) * 2012-07-17 2014-01-23 Dow Global Technologies Llc Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
US3501571A (en) * 1965-12-06 1970-03-17 Smithkline Corp Novel silicone compositions and method of preparing same
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant

Also Published As

Publication number Publication date
US3853988A (en) 1974-12-10
FR2110314A1 (OSRAM) 1972-06-02
DE2149699A1 (de) 1972-04-13
FR2110314B1 (OSRAM) 1975-06-06
GB1357737A (en) 1974-06-26
CA974883A (en) 1975-09-23
DK129434B (da) 1974-10-14
ES395533A1 (es) 1974-10-16
DK129434C (OSRAM) 1975-03-10

Similar Documents

Publication Publication Date Title
SE393800B (sv) Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt
SE413578B (sv) Forfarande for framstellning av orala lekemedelspreparat med forlengda verkningstider
SE385872B (sv) Forfarande for framstellning av vissa angivna p-karbonyl - fenoxi - iso - smorsyraestrar
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE409460B (sv) Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika
NO138630C (no) Fremgangsmaate for fremstilling av 7beta-acylamido-3-metyl-ceph-3-em-4-karboksylsyre-estere
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE382560B (sv) Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring
SE7611315L (sv) Prostansyraderivat och sett for framstellning derav
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE403911B (sv) Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan
IL37467A0 (en) Derivatives of benzopyran-2-carboxylic acid,their preparation and pharmaceutical compositions containing them
IL40457A0 (en) New esters and salts of oburnamine type alkaloids,their preparation and pharmaceutical compositions containing them
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE420919B (sv) Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE406195B (sv) Forfarande for framstellning av bensocykloheptaisokinolinderivat samt syraadditionssalter derav
SE396010B (sv) Forfarande for framstellning av aktiva emnen innehallande preparat med langvarig verkan i form av tabletter, drageer eller kapslar
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE385471B (sv) Forfarande for framstellning av bensobicykloalkanaminer med analgetisk eller anti-inflammatorisk lekemedelsverkan
SE402111B (sv) Analogiforfarande for framstellning av pregnansyraderivat
SE380517B (sv) Forfarande for framstellning av fluoren-2-ettiksyraderivat med antiinflammatorisk verkan
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
IL30307A0 (en) Novel derivatives of acetic acid,their preparation and pharmaceutical compositions containing them